Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Q2 2025 vs. Q1 2025

How the institutions holding iTeos Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ITOS: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders132137+5
Shares37.0M37.8M+848.1K (+2.3%)
Value$220.7M$377.0M+$156.3M (+70.8%)

New holders (40)

Institutions that held iTeos Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ITOS in Q2 2025
InstitutionSharesValue% of portfolio
EcoR1 Capital, LLC10,688,978$106.6M6.32%
Boxer Capital Management, LLC825,000$8.23M4.14%
OrbiMed Advisors LLC700,000$6.98M0.18%
Nantahala Capital Management, LLC596,666$5.95M0.42%
DLD Asset Management, LP576,655$5.75M0.68%
Newtyn Management, LLC567,416$5.66M0.86%
LMR Partners LLP550,000$5.48M0.09%
Alyeska Investment Group, L.P.500,000$4.99M0.02%
Rangeley Capital, LLC302,080$3.01M3.79%
Silver Point Capital L.P.290,000$2.89M0.20%
Alpine Global Management, LLC225,000$2.24M0.51%
Shay Capital LLC210,516$2.10M0.48%
Diadema Partners LP206,200$2.06M1.28%
Susquehanna Portfolio Strategies, LLC204,708$2.04M0.04%
Gabelli & Co Investment Advisers, Inc.146,450$1.46M0.22%
Gabelli Funds LLC120,593$1.20M0.01%
Simplex Trading, LLC103,212$1.03M0.03%
Campbell & CO Investment Adviser LLC72,262$720.5K0.05%
FNY Investment Advisers, LLC65,000$648.0K0.28%
Regency Capital Management Inc.58,000$578.3K0.30%
Clearline Capital LP55,013$548.5K0.05%
State of Wisconsin Investment Board48,096$479.5K0.00%
Persistent Asset Partners Ltd47,512$473.7K0.41%
Vazirani Asset Management LLC35,000$348.9K1.33%
XTX Topco Ltd34,777$346.7K0.01%
Bluefin Capital Management, LLC30,530$304.4K0.24%
Nebula Research & Development LLC28,909$288.2K0.02%
Proficio Capital Partners LLC24,865$247.9K0.02%
Sandia Investment Management LP24,865$247.9K0.64%
Two Sigma Advisers, LP18,000$179.5K0.00%
Bailard, Inc.15,200$151.5K0.00%
Axq Capital, LP13,860$138.2K0.04%
Aigen Investment Management, LP11,291$112.6K0.02%
Quantinno Capital Management LP10,305$102.7K0.00%
Skopos Labs, Inc.556$5.54K0.00%
Essential Partners LLC378$3.77K0.00%
Raymond James Financial Inc125$1.25K0.00%
Farther Finance Advisors, LLC120$1.20K0.00%
Allworth Financial LP40$3990.00%
Clearstead Advisors, LLC13$1300.00%

Sold out (35)

Institutions that held iTeos Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.